Brief: YS Biopharma Granted Phase I Clinical Trial License Of Therapeutic Chronic Hepatitis B Virus Vaccine
18/04/2024 13:03
April 18 (Reuters) - YS Biopharma Co Ltd H6Z.F :
* YS BIOPHARMA GRANTED PHASE I CLINICAL TRIAL LICENSE OF
THERAPEUTIC CHRONIC HEPATITIS B VIRUS VACCINE
* YS BIOPHARMA CO LTD - PREPARING TO INITIATE A PHASE I
CLINICAL
TRIAL FOR YS-HBV-002 IN PHILIPPINES, WHICH IS EXPECTED TO BEGIN
IN JUNE 2024
Source text for Eikon: ID:nPnNsRsHa
Further company coverage: H6Z.F
Recent news on LakeShore Biopharma Co
See all newsBrief: LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq
Brief: LakeShore Biopharma Appoints Advisors to Special Committee Reviewing Takeover Bid
Brief: Lakeshore Biopharma Announces Receipt Of A Preliminary Non-Binding Proposal To Acquire The Company
Brief: Lakeshore Biopharma Expects 2026 Revenue To Be Between RMB550 Million And RMB650 Million
Brief: Lakeshore Biopharma Announces Us$15 Million Private Placement Financing